BMS, Sanofi Pushed Docs To Overprescribe Plavix, Suit Says
Bristol-Myers Squibb Co. and Sanofi SA faced more fallout Monday from long-simmering reports that their blood-thinner Plavix carries internal injury risks as more than three dozen users and their survivors claimed...To view the full article, register now.
Already a subscriber? Click here to view full article